Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by
insiders of AVI BIOPHARMA INC since year 2005 are given in the first table.
The second table lists detailed insider transactions reported by AVI BIOPHARMA INC since 2005.
The reporting company's ticker symbol is AVII.
The reporting company's CIK number is 873303.
The total value of stock buying during this period is $1,962,982.
The total value of stock sales is $2,327,844.
The total value of stock exercises is $0.
Figure 1. Monthly insider transaction values at AVI BIOPHARMA INC (AVII) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
06
07
08
09
10
11
12
01 2007
02
03
04
05
06
07
08
09
10
11
12
01 2008
02
03
04
05
$1,516k
$151k
$15k
$1k
Buy
Sale
Option Exercise
Figure 2. Average prices of insider buys, sales, and option exercises at AVI BIOPHARMA INC (AVII) in the past 24 months. See table 2 for insider transaction details.
06
07
08
09
10
11
12
01 2007
02
03
04
05
06
07
08
09
10
11
12
01 2008
02
03
04
05
$2.89
$2.17
$1.45
$.72
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for AVI BIOPHARMA INC (AVII).
Trading Period year-month
Insider Buying Shares Value ($)
Insider Sales Shares Value ($)
Option Exercises Shares Value ($)
2008-03
687,470
1,114,879
0
0
0
0
2008-02
573,200
787,603
0
0
0
0
2006-08
0
0
300,000
811,380
0
0
2006-07
0
0
540,000
1,516,464
0
0
2006-03
5,000
31,800
0
0
0
0
2005-11
2,000
6,740
0
0
0
0
2005-09
10,000
21,960
0
0
0
0
Table 2. Detailed insider stock purchases, sales, and option exercises
for AVI BIOPHARMA INC (AVII)
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of AVI BIOPHARMA INC (symbol AVII,
CIK number 873303) see
the Securities and Exchange Commission (SEC) website.
